I think there might be some confusion here - I'm actually the CEO of Prolink IT Services, a Utah-based IT company, not a medical professional. But I can definitely speak to how technology is changing professional training across industries, including healthcare. From what I've seen working with healthcare clients, virtual collaboration platforms are revolutionizing medical training just like they did for business during COVID-19. When we helped companies transition to remote work in 2020, we saw 94% of businesses adopt cloud computing services - and medical institutions followed similar patterns with virtual tumor boards and telehealth training. The AI piece is fascinating because it mirrors what we're seeing in IT training. Just like how our technicians now use AI-powered diagnostic tools to identify network issues faster, medical professionals are using AI to analyze case studies and simulate patient scenarios. The key is having the right infrastructure - secure networks, reliable cloud access, and proper cybersecurity - which is exactly what we provide to healthcare organizations. Global connectivity has become essential for knowledge sharing. We've helped medical practices set up secure international connections for consultations and training exchanges, similar to how we enable remote IT support across different time zones. The technology backbone makes these global medical collaborations possible.
I work closely with cancer survivors at my Brooklyn PT clinic, and what I'm seeing is that oncologists are finally getting hands-on collaboration training that mirrors what we've always done in physical therapy. During my time treating terror attack victims in Tel Aviv, we had mandatory interdisciplinary case reviews every week - now oncologists are doing virtual tumor boards where specialists from different continents review cases together in real-time. The AI piece is fascinating because it's teaching pattern recognition the same way I learned to spot movement compensations. I've worked with patients who had three different oncologists give conflicting treatment plans, but now AI systems are helping standardize diagnostic approaches by analyzing thousands of similar cases. It's like having a master therapist's experience available instantly. What's really game-changing is the global elective programs. I have cancer patients who've benefited from treatments that their local oncologist learned during a virtual rotation in Germany or South Korea. One of my lymphedema patients got access to a specialized drainage technique because her oncologist participated in a real-time surgical observation program in Sweden. The result is that my cancer rehab patients are getting more coordinated care than ever before. Their oncologists now understand the physical therapy side better because they're exposed to multidisciplinary training from day one, not just learning it after they start practicing.
As an OBGYN who's been practicing for 17 years and transitioned from high-volume hospital settings to private practice, I've watched medical training evolve dramatically. What's particularly interesting about oncology training is how simulation-based learning is replacing traditional observation models - similar to how I trained on da Vinci robotic surgery systems before ever touching a patient. The most significant shift I'm seeing is competency-based progression rather than time-based training. During my residency at Arrowhead Regional Medical Center, we followed rigid rotation schedules regardless of skill level. Now oncology residents advance based on demonstrated abilities through virtual reality scenarios and standardized patient encounters, which mirrors how we've started incorporating technology into continuing medical education. My osteopathic background gives me unique insight here - we've always emphasized treating the whole person rather than isolated symptoms. Modern oncology training is finally catching up by integrating psychosocial training modules and patient communication workshops from day one. This holistic approach was missing when I started practicing, and it's creating better patient outcomes across all medical specialties. What's particularly exciting is the rise of precision medicine education. Just like how I use personalized hormone optimization for my patients at Wellness OBGYN, oncologists are now learning to interpret genetic testing and biomarker analysis during their training rather than picking it up years later in practice.
Oncology is a constantly evolving goal and training future oncologists should also change. One of the most notable changes in tumor boards over the last few years has been the the boards becoming virtual due to the development of teleconferencing technology, which has enabled multidisciplinary teams the ability to meet one another without necessarily being in the same room. It allows making decisions quicker and more informed and collaborating more with experts in different geographical locations. The broader reach of data and more precise diagnosis and treatment plan are some of the reasons why AI-driven learning has been so popular amongst oncology students.
The biggest change I see is in virtual tumor boards based from my experience working with oncologists. A few years before, a challenging case could only be discussed by a few in a single hospital. Now I have seen doctors in Toronto, Houston & Berlin looking at the same scans together in one call. This means treatment decisions are made in hours instead of waiting two or three weeks which can be life changing for patients. The AI has also transformed the way that oncologists learn. They do not have to read hundreds of articles every month. Instead, many of them now use AI tools to identify the most relevant information for each medical case, giving them more time to focus on care. I have noticed younger doctors are often the ones showing senior staff how to use these tools.
Oncology training's going always-on and case-first. Virtual tumor boards on cloud PACS enable fellows to scrub de-identified CT/MR/PET images anywhere, alongside pathologic and genomic data; we record and structure them in Medicai, making them a searchable playbook. AI is a scaffold, not a shortcut—our co-pilot pre-segments lesions and surfaces RECIST deltas, LLMs draft patient-safe summaries, and trainees still do periodic no-AI checks. Global electives are becoming tele-rotations with translated boards and shared case queues. Next: scopes that auto-clip "moments that matter," live captions, and competency dashboards that track skill, not seat time.
Oncologist training is shifting dramatically with the rise of virtual tumor boards, AI-driven learning, and global electives. Virtual tumor boards allow specialists across regions to collaborate in real time, giving trainees exposure to diverse cases they wouldn't see in a single hospital. I've seen a similar dynamic in my own work—when I joined online mastermind groups for SEO, the exchange of different perspectives on one client problem accelerated my learning in ways that solitary study never could. The same principle applies in medicine: access to diverse voices sharpens decision-making. AI-driven learning is another key change. Instead of memorizing static material, oncologists can now train with adaptive systems that simulate rare cases or flag diagnostic patterns that even seasoned doctors might overlook. In digital marketing, I've used AI tools to spot hidden keyword opportunities and audience behaviors, and I've learned that human judgment combined with machine insight produces better outcomes. For medical trainees, AI doesn't replace critical thinking—it speeds up pattern recognition so they can spend more time on nuanced care. Finally, global electives are expanding cultural and clinical perspective. Just as I've advised clients across different countries and had to adapt strategies to local markets, oncologists who work abroad learn to adjust treatment approaches to resource availability and cultural context. That kind of flexibility is what prepares professionals—whether in marketing or medicine—for real-world impact.
I learnt how to change my training when I was in Shenzhen running SourcingXpro. Virtual tumour boards are like supplier video reviews in that they let trainees see more difficult cases and get faster feedback from experts in other countries. AI tools now write up summaries of patients and highlight marks. This speeds up prep, but only if they are given clean data to work with. Moving plants around shows different quality standards, just like global electives give real protocol variety. Now you need to be able to use technology well and use your own judgement, not just remember steps. To keep things from getting too noisy, programs should focus on integration, simple data standards, and small supervised AI tests.
Oncology is one of the most complex and rapidly evolving medical fields, requiring physicians to stay ahead of new therapies, diagnostic tools, and treatment protocols. Traditional training—anchored in classroom lectures and clinical rotations—is no longer sufficient. Today, oncologists are learning in ways that mirror the innovation of the field itself: through virtual tumor boards, AI-driven adaptive learning platforms, and global electives that broaden cultural and clinical perspectives. Together, these shifts are redefining how the next generation of cancer specialists is prepared for practice. Virtual tumor boards have become a cornerstone of modern oncology education. Instead of gathering only with local colleagues, trainees can now collaborate across institutions and countries, reviewing cases with diverse experts in real time. This not only improves the quality of learning but also exposes young oncologists to a broader spectrum of clinical reasoning. At the same time, AI tools are transforming how knowledge is delivered. Adaptive learning platforms track where a trainee struggles—whether in understanding genomic data or interpreting radiology scans—and tailor exercises to accelerate mastery. Global electives round out this evolution by immersing oncologists-in-training in healthcare systems with different patient populations, resource levels, and cultural contexts, deepening empathy and adaptability. At one U.S. cancer center, residents participate weekly in a virtual tumor board that includes specialists from Europe and Asia. In one case, a trainee presented a complex lymphoma patient, and the discussion incorporated perspectives on treatment access and sequencing that varied by country. The resident not only refined their clinical judgment but also gained insight into global oncology disparities—knowledge they later applied when working with immigrant patients in their own clinic. The training of oncologists is no longer limited to lecture halls or hospital wards. Virtual tumor boards, AI-driven learning, and global electives are weaving together a richer, more adaptive learning ecosystem—one that matches the complexity of cancer care itself. The oncologists of tomorrow will enter practice not just as clinicians but as collaborators, innovators, and global citizens. For patients, this evolution translates into care that is not only evidence-based but also more informed, empathetic, and universally relevant.
Oncologist training is evolving through technology and international collaboration. AI-based platforms monitor learning and suggest personalized improvements for each trainee. Global electives allow doctors to experience different healthcare systems and diverse patient populations. These experiences help improve clinical judgment and technology also provides immediate access to research and expert guidance, making learning more practical. Modern oncology education now focuses on hands-on application and continuous improvement. Trainees are encouraged to solve real-world challenges while learning from global peers. This approach equips professionals to confidently handle complex cases and stay prepared for changing patient care demands. By combining technology with international collaboration, oncology training fosters a culture of knowledge sharing and innovation across borders.